Lupizotib 60mg Tablet

About

Lupizotib 60mg Tablet is a targeted therapy belonging to the class of tyrosine kinase inhibitors (TKIs). It functions by selectively inhibiting specific tyrosine kinases that are crucial for cell growth, proliferation, and survival in various cancer types. By blocking these aberrant signaling pathways, Lupizotib can effectively impede tumor growth and progression. This targeted approach offers a more precise way to combat cancer cells while potentially sparing healthy cells to a greater extent than traditional chemotherapy.

The drug is designed to interfere with the molecular mechanisms that drive cancer development, making it a valuable option for patients whose tumors exhibit specific genetic mutations or overexpression of certain receptors. Its efficacy is often linked to the presence of these biomarkers, which guide treatment selection. The oral administration provides convenience for long-term management, allowing patients to receive treatment outside of a hospital setting, thereby improving their quality of life during therapy.

Uses

• Treatment of non-small cell lung cancer (NSCLC)
• Management of chronic myeloid leukemia (CML)
• Treatment of renal cell carcinoma (RCC)
• Management of gastrointestinal stromal tumors (GIST)

Directions For Use

Take orally once daily with or without food, as prescribed by your oncologist. Swallow the tablet whole; do not crush, chew, or split it.

Benefits

• Targets specific cancer-driving pathways
• Effective in various solid tumors and hematologic malignancies
• Improves progression-free survival
• Reduces tumor burden
• Oral administration for patient convenience
• Potential for fewer systemic side effects than traditional chemotherapy

Side Effects

• Diarrhea
• Fatigue
• Nausea
• Skin rash
• Hypertension
• Hand-foot syndrome
• Elevated liver enzymes
• Proteinuria
• Stomatitis
• Headache
• Abdominal pain
• Decreased appetite

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may exacerbate liver toxicity associated with this medication.
• Pregnancy - Contraindicated during pregnancy due to potential teratogenic effects. Use effective contraception during and after treatment.
• Breastfeeding - Not recommended during breastfeeding as it is unknown if the drug is excreted in breast milk and could harm the infant.
• Liver - Use with extreme caution in patients with liver impairment. Dose adjustments are often required, and liver function should be closely monitored.
• Kidney - Use with caution in patients with kidney conditions. Dose adjustments may be necessary based on renal function.
• Lung - Monitor for symptoms of interstitial lung disease (ILD). Use with caution in patients with pre-existing lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.